Peptide vaccine formulation controls the duration of antigen presentation and magnitude of tumor-specific CD8+ T cell response

Despite remarkable progresses in vaccinology, therapeutic cancer vaccines have not achieved their full potential. We previously showed that an excessively long duration of antigen presentation critically reduced the quantity and quality of vaccination-induced T cell responses and subsequent anti-tum...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Immunol
Main Authors: Khong, Hiep, Volmari, Annika, Sharma, Meenu, Dai, Zhimin, Imo, Chinonye S., Hailemichael, Yared, Singh, Manisha, Moore, Derek T., Xiao, Zhilan, Huang, Xue-fei, Horvath, Thomas D., Hawke, David H., Overwijk., Willem W.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940548/
https://ncbi.nlm.nih.gov/pubmed/29643190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1700467
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki